DOI:

Complete removal of extensive right coronary artery thrombus by the use of an aspiration catheter to facilitate primary angioplasty

Ajay K. Jain, BSC, MRCP; R. Andrew Archbold*, MD, MRCP

A 67 year old man with a one-hour history of chest pain due to acute inferior ST elevation myocardial infarction underwent coronary angiography after treatment with aspirin 300 mg, clopidogrel 600 mg, and a weight-adjusted abciximab bolus. The culprit lesion was a proximal occlusion of the right coronary artery (panel A). Passage of a 0.014” angioplasty wire through the occlusion restored TIMI I antegrade flow, which revealed a severe stenosis in the proximal right coronary artery (RCA) in association with a large thrombus extending to the acute margin (panel B). Angiographically visible thrombus was completely removed by the use of an aspiration catheter (Export Catheter, Medtronic, USA) (panel C). The stenosis was then stented with a 5.0 x 20 mm Liberte™ (Boston Scientific, USA) stent with no angiographic evidence of distal embolisation or no-reflow (panel D). The patient was discharged 48 hours later.

A large thrombus burden in the infarct-related artery poses technical and therapeutic challenges during percutaneous coronary intervention. Furthermore, its presence is associated with adverse angiographic and clinical outcomes. Conventional management employs combination antiplatelet therapy that includes an infusion of a glycoprotein IIb/IIIa receptor inhibitor, but the role of mechanical thrombectomy devices remains contentious. These images demonstrate that the use of an aspiration catheter can dramatically reduce thrombus load in these patients. This facilitates the procedure through better visualisation of the lesion, allowing appropriate stent selection, and it may reduce the propensity to no-reflow. Whether or not there is a clinical advantage from the use of such devices, however, remains to be determined.

Volume 3 Number 1
May 22, 2007
Volume 3 Number 1
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00601 Jun 15, 2026
Unloading the clock: when timing meets physiology in STEMI shock
Møller J and Schrage B
free

Editorial

10.4244/EIJ-D-26-00394 Jun 15, 2026
Transcatheter edge-to-edge repair for primary mitral regurgitation: what lies ahead?
Petronio A and Mazzola M
free

Original Research

10.4244/EIJ-D-25-01308 Jun 15, 2026
Temporal trends in mitral edge-to-edge repair for primary mitral regurgitation
Koell B et al

Flashlight

10.4244/EIJ-D-25-01353 Jun 15, 2026
Transcatheter approximation of papillary muscles
Tekieli L et al
open access

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free
Trending articles
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
35.3

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved